Charles River Laboratories International Investors

Charles River Laboratories International provides research models and outsourced preclinical services for the accelerated R&D of drugs.

Last Funding Type: Post-IPO Debt
Funding Status: IPO
Headquarters: Wilmington, Massachusetts, United States
Founded Date: 1947-01-01
Last Funding Date: 2021-03-23
Total Funding: 1534000000.0
Technology: Drug Delivery
Employee Number: 5001-10000
Number Of Exists: 1
Acquisitions Number: 32
Estimated Revenue: $500M to $1B
Investors Number: 1.0
Industry: Early Drug Development